Cite
HARVARD Citation
Hasanov, E. et al. (2021). MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma. Expert opinion on investigational drugs. pp. 495-504. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hasanov, E. et al. (2021). MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma. Expert opinion on investigational drugs. pp. 495-504. [Online].